Comera Life Sciences News

Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option

WOBURN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB:CMRA) ("Comera" or the "Company"), a life sciences company developing a proprietary drug-delivery technology to improve

GlobeNewswireJan 4 08:30 ET

Comera Life Sciences Announces Process Exploring Strategic Alternatives

WOBURN, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB:CMRA) ("Comera" or the "Company"), a life sciences company developing a new generation of biologic medicines to improve

GlobeNewswireDec 6, 2023 08:30 ET

Comera Life Sciences(CMRA.US) Officer Buys US$708 in Common Stocks

$Comera Life Sciences(CMRA.US)$ Officer Campbell Michael Gerard purchased 10,000 shares of Common Stocks on Nov 27, 2023 at an average price of $0.0708 for a total value of $708.Source: Announcement W

moomoo NewsNov 28, 2023 17:05 ET

Comera Life Sciences Designates Dorothy Clarke to Board of Directors

Yahoo FinanceNov 13, 2023 19:59 ET

Comera Life Sciences Appoints Dorothy Clarke to Board of Directors

Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) today announced it appointed Dorothy Clarke to its board of directors.

GlobeNewswireNov 13, 2023 08:00 ET

Comera Life Sciences Q3 EPS $(0.10) Up From $(0.20) YoY, Sales $136.31K Down From $234.92K YoY

Comera Life Sciences (NASDAQ:CMRA) reported quarterly losses of $(0.10) per share. This is a 50 percent increase over losses of $(0.20) per share from the same period last year. The company reported

BenzingaNov 9, 2023 08:18 ET

Earnings Flash (CMRA) COMERA LIFE SCIENCES Posts Q3 Revenue $136,310

08:07 AM EST, 11/09/2023 (MT Newswires) -- Earnings Flash (CMRA) COMERA LIFE SCIENCES Posts Q3 Revenue $136,310

MT NewswiresNov 9, 2023 08:07 ET

Comera Life Sciences 3Q Loss/Shr 10c >CMRA

Comera Life Sciences 3Q Loss/Shr 10c >CMRA

Dow JonesNov 9, 2023 08:02 ET

12 Health Care Stocks Moving In Tuesday's Intraday Session

GainersLianBio (NASDAQ:LIAN) shares moved upwards by 128.1% to $3.17 during Tuesday's regular session. Trading volume for this security as of 13:31 EST is 77.9 million, which is 39428.4% of its averag

BenzingaOct 24, 2023 13:31 ET

Comera Life Sciences Presents SQore Platform Technology Data at PODD: Partnerships in Drug Delivery Conference

Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) today will present research demonstrating Comera's SQore platform capabilities in the development of subcutaneous monoclonal antibody formulations at the PODD: Partnerships in Drug Delivery conference in Boston, Mass.

GlobeNewswireOct 16, 2023 08:00 ET

12 Health Care Stocks Moving In Friday's Intraday Session

GainersBio-Path Hldgs (NASDAQ:BPTH) shares rose 60.6% to $0.63 during Friday's regular session. Bio-Path Hldgs's stock is trading at a volume of 111.1 million shares as of 13:30 EST. This is 15820.7%

BenzingaOct 13, 2023 13:31 ET

12 Health Care Stocks Moving In Thursday's After-Market Session

GainersBio-Path Hldgs (NASDAQ:BPTH) stock increased by 158.8% to $1.02 during Thursday's after-market session. Today's trading volume for this security ended up closing at 18.9 million shares, which i

BenzingaOct 12, 2023 17:31 ET

12 Health Care Stocks Moving In Friday's After-Market Session

GainersBionomics (NASDAQ:BNOX) stock moved upwards by 24.0% to $3.46 during Friday's after-market session. Today's trading volume for this security ended up closing at 1.8 million shares, which is 85.

BenzingaSep 29, 2023 17:31 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersRocket Pharmaceuticals (NASDAQ:RCKT) stock rose 29.6% to $19.81 during Tuesday's after-market session. Rocket Pharmaceuticals's trading volume hit 792.9K shares by close, accounting for 130.7%

BenzingaSep 12, 2023 17:31 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersAcer Therapeutics (NASDAQ:ACER) stock increased by 70.5% to $1.04 during Thursday's pre-market session. The company's market cap stands at $25.4 million. Allarity Therapeutics (NASDAQ:ALLR) sto

BenzingaAug 31, 2023 09:06 ET

Comera Life Sciences Files Prospectus For The Offer And Resale Of 27,863,058 Shares Of Common Stock By Selling Stockholders

Comera Life Sciences Files Prospectus For The Offer And Resale Of 27,863,058 Shares Of Common Stock By Selling Stockholders

BenzingaAug 29, 2023 16:44 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

GainersAxcella Health (NASDAQ:AXLA) shares increased by 222.2% to $0.36 during Tuesday's pre-market session. The company's market cap stands at $26.7 million. Tivic Health Systems (NASDAQ:TIVC) stock

BenzingaAug 29, 2023 09:06 ET

12 Health Care Stocks Moving In Monday's Pre-Market Session

GainersBionomics (NASDAQ:BNOX) stock increased by 15.0% to $1.76 during Monday's pre-market session. The company's market cap stands at $14.3 million. Geovax Labs (NASDAQ:GOVX) shares moved upwards by

BenzingaAug 28, 2023 09:06 ET

Comera Life Sciences Announces Publication Of Study Reinforcing Caffeine's Viscosity Reducing Capabilities

Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous formulations of monoclonal antibodiesWOBURN, Mass., Aug.

BenzingaAug 16, 2023 08:15 ET

Comera Life Sciences Q2 EPS $(0.08) Up From $(1.14) YoY, Sales $315.06K Up From $146.73K YoY

Comera Life Sciences (NASDAQ:CMRA) reported quarterly losses of $(0.08) per share. This is a 92.98 percent increase over losses of $(1.14) per share from the same period last year. The company report

BenzingaAug 10, 2023 08:08 ET